FDA approves Biogen’s aducanumab
Aduhelm (aducanumab) is the first new dementia drug treatment to come to market since 2003.
News & events
News, conferences, events, blogs and updates from across the field of dementia and the work of Alzheimer's Disease International.
Featured news and events
Life in a dementia care centre during India’s second COVID-19 wave: Part one
In this four part series, Senju Joseph, a carer at the Dementia Respite care centre in Thrissur, India, documents his experience of navigating the catastrophic second COVID-19 wave.
Welcome to our new website
We have a new website, with updated design and content. The site works better on mobile devices and brings together our resources, member information and programmes so they are easy to find.
Souvenaid results offer hope for those with early Alzheimer’s disease, including Mild Cognitive Impairment
Promising results from a clinical trial have been published in the peer-reviewed journal of the Alzheimer’s Association.
Evidence considered at FDA Advisory Committee for potential first new Alzheimer’s disease treatment in decades
The US Food and Drug Administration has reviewed clinical trial data for Biogen’s drug aducanumab, which aims to treat cognitive and functional decline in Alzheimer’s disease.
Designing to support dignity and independence
Fiona Walsh writes about designing around the different challenges a person with dementia may experience – and how these design decisions can have a significant impact on a person’s dignity and independence
ADI, Global Coalition on Aging and Lien Foundation launch new Dementia Innovation Readiness Index
‘Dementia Innovation Readiness Index 2020: 30 Global Cities’ calls strongly for cities to fulfil their commitments under the WHO’s Global action plan on dementia to engage fully with their national dementia plans.
COVID-19 has just made the Mount Everest of social care twice as hard to climb
On World Alzheimer’s Day, Hilary Doxford, a dementia advocate and member of the 3 Nations Dementia Working Group and World Dementia Council, shares her views and experiences – as well as those of her friends and fellow advocates – of living with dementia in the UK during the Covid-19 pandemic.